Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

ER 30346

Known as: ER-30346 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2002
2002
Ravuconazole (BMS-207147, ER-30346), an oral triazole, was evaluated in an immunosuppressed temporarily neutropenic guinea pig… Expand
Is this relevant?
2002
2002
Ravuconazole (BMS 207147, ER-30346) is a long-lasting triazole antifungal agent active against a broad spectrum of fungal… Expand
  • figure 1
  • table 1
Is this relevant?
1999
1999
  • Drugs in R&D
  • 1999
  • Corpus ID: 46522873
 
Is this relevant?
1998
1998
The antifungal activity of BMS-207147 (also known as ER-30346) was compared to those of itraconazole and fluconazole against 250… Expand
  • table 1
  • table 2
  • table 3
  • table 5
  • table 6
Is this relevant?
Highly Cited
1998
Highly Cited
1998
A series of azole antifungal agents featuring a quinazolinone nucleus have been subjected to studies of structure-activity… Expand
Is this relevant?
1998
1998
A series of novel thiazole-containing triazole antifungals was synthesized and evaluated for antifungal activity against a… Expand
Is this relevant?
1996
1996
ER-30346 is a novel oral triazole with a broad spectrum of potent activity against a wide range of fungi. ER-30346, with MICs at… Expand
Is this relevant?
1996
1996
ER-30346 is a novel oral triazole with a broad spectrum of potent activity against a wide range of fungi. In the present study… Expand
Is this relevant?